In this area our teams are elucidating the biochemical and cellular basis of human diseases and the molecular mechanisms underlying drug action and their targets.
Our investigation of disease mechanisms provides insights into identification of novel therapeutic targets for which small molecules or biologics are being developed. Research is directed towards the molecular and cellular mechanisms underlying the function of therapeutic targets, correcting the target using gene therapy, and the intracellular signalling pathways they control and the mechanistic study of drug action. Approaches incorporate human studies, patient-derived samples and animal models of disease. Our research teams are interested in several human diseases or conditions including drug addiction, autism, diabetes, cancer, genetic disorders, infectious diseases, and neurological diseases.
Investigators
Research News
Image
Pharmacy alum’s research shows how full-scope practice improves cancer care
Honoured with a national award, Adrian de Boer says his residency experience was a powerful reminder that he's making a meaningful change to the pharmacy profession.
Read More
Image
Pharmacy alum passionate about helping community pharmacists practice to full scope
As a pharmacy leader at Rexall, Heidi Wittke uses frontline experience to lead initiatives that improve patient care
Read More
Image
Bridging Research and Industry: GRIP 2025 highlights innovation and real-world impact
Over 200 attendees from academia, healthcare, and industry gathered last week for the 2025 GRIP symposium, celebrating the depth and diversity of graduate student research.
Read More